Thoracic MRI evaluation of sarcoidosis in children. Issue 4 (31st October 2016)

• Record Type: Journal Article
• Authors: Gorkem, Sureyya Burcu; Köse, Seçil; Lee, Edward Y.; Doğanay, Selim; Coskun, Ayse Seda; Köse, Mehmet
• Is Part Of: Pediatric pulmonology. Volume 52:Issue 4(2017)
• Page Start: 494
• Page End: 499
• Publication Date: 2016-10-31
• Subjects: sarcoidosis -- children -- lung -- MRI -- CT; Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.23614
• Languages: English
• ISSNs: 8755-6863

Abstract

Summary: Background: Childhood sarcoidosis is a very rare granulomatous disorder with an unknown etiology. Stage 1 disease is the most common whereas stages 2, 3, and 0 are rare in children. Objective: To evaluate thoracic findings of pediatric pulmonary sarcoidosis on MRI and to compare them with CT findings. Methods: Between August 2010 and May 2015, seven consecutive pediatric patients (four male, three female; age range: 8–18 years, mean age: 13.5 ± 3.01 years) who were diagnosed with sarcoidosis were enrolled in our study prospectively. Inclusion criterion was patients with stages 1–4 sarcoidosis who underwent contrast enhanced chest CT for initial diagnosis or follow‐up evaluation of thoracic findings and exclusion criteria were patients with stage 0 disease with extra‐pulmonary manifestations (n = 4). Results: Two patients who recovered from stage 2 to stage 0 were interpreted as normal. Five patients had abnormal findings on chest CT, including hilar/mediastinal lymphadenopathy (n = 5, 71%), nodules larger than 3 mm (n = 4, 57%), ground glass opacity (n = 4, 57%), thickening of the pleura/fissure (n = 3, 42%), interlobular septal thickening (n = 2, 28%), atelectasis (n = 1, 14%), consolidation (n = 1, 14%), bronchiectasis (n = 1, 14%), intraparenchymal and subpleural cysts (n = 1, 14%), fibrotic bands (n = 1, 14%), and enlarged pulmonary artery (n = 1, 14%). Findings that were detected on CT but not observed by lung MRI were nodules <3 mm (n = 4, 57%), mild bronchiectasis and mild ground glass opacity (n = 1, 14%), and subpleural and intraparenchymal cysts (n = 1, 14%). The sensitivity and specificity of MRI were 85.2% and 100%, respectively. There was no statistically significant difference between lung MRI and CT in detecting the thoracic findings in stages 1, 2, and 4 sarcoidosis ( P = 0.1336, 95%Cl). Conclusion: Contrast‐enhanced lung MRI with fast imaging sequences is a highly sensitive imaging modality and comparable with CT in evaluating both lung and cardiac abnormalities in pediatric sarcoidosis. Given there is no associated ionizing radiation, chest MRI is a promising imaging modality in this pediatric patient population. Pediatr Pulmonol. 2017;52:494–499. © 2016 Wiley Periodicals, Inc.